AdaptHealth Corp.
AHCONASDAQHealthcare● Active
$9.89
+$0.16(+1.64%)
Market Cap$1.3B
P/E Ratio—
52W High$13.43
52W Low$8.06
AdaptHealth Corp. (AHCO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AHCO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
-$0.06
Est. $0.01 · -580.0%
Revenue
$0.82B
Est. $0.80B · +2.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
AHCO reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.84B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.84B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.15 | — | — | — | $0.85B | — |
| ▼ Q2 FY2026 | May 5, 2026 | $0.01 | -$0.06 | -580.0% | $0.82B | $0.80B | +2.9% |
| ▼ Q1 FY2026 | Feb 24, 2026 | $0.34 | $0.27 | -20.6% | $0.85B | $0.83B | +1.8% |
| ▼ Q4 FY2025 | Nov 4, 2025 | $0.24 | $0.22 | -8.3% | $0.82B | $0.83B | -1.5% |
| ▼ Q3 FY2025 | Aug 5, 2025 | $0.15 | $0.01 | -93.3% | $0.80B | $0.80B | +0.1% |
| — Q2 FY2025 | May 6, 2025 | $0.01 | $0.01 | +0.0% | $0.58B | $0.81B | -28.2% |
| ▲ Q1 FY2025 | Feb 25, 2025 | $0.25 | $0.39 | +56.0% | $0.86B | $0.80B | +6.8% |
| ▼ Q4 FY2024 | Nov 5, 2024 | $0.17 | $0.15 | -11.8% | $0.81B | $0.83B | -2.8% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.15
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Miss
EPS Actual
-$0.06
EPS Est.
$0.01
EPS Surpr.
-580.0%
Revenue
$0.82B
Q1 FY2026
Feb 24, 2026Miss
EPS Actual
$0.27
EPS Est.
$0.34
EPS Surpr.
-20.6%
Revenue
$0.85B
Q4 FY2025
Nov 4, 2025Miss
EPS Actual
$0.22
EPS Est.
$0.24
EPS Surpr.
-8.3%
Revenue
$0.82B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
$0.01
EPS Est.
$0.15
EPS Surpr.
-93.3%
Revenue
$0.80B
Q2 FY2025
May 6, 2025
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
+0.0%
Revenue
$0.58B
Q1 FY2025
Feb 25, 2025Beat
EPS Actual
$0.39
EPS Est.
$0.25
EPS Surpr.
+56.0%
Revenue
$0.86B
Q4 FY2024
Nov 5, 2024Miss
EPS Actual
$0.15
EPS Est.
$0.17
EPS Surpr.
-11.8%
Revenue
$0.81B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $0.57 | $0.58 | $0.59 | 1 |
| Q4 FY2028 | $0.42 | $0.43 | $0.44 | 2 |
| Q3 FY2028 | $0.34 | $0.35 | $0.35 | 2 |
| Q2 FY2028 | $0.06 | $0.07 | $0.07 | 2 |
| Q1 FY2028 | $0.49 | $0.50 | $0.51 | 2 |
| Q4 FY2027 | $0.36 | $0.37 | $0.38 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $1.0B | $1.0B | $1.1B | 2 |
| Q4 FY2028 | $1.0B | $1.0B | $1.0B | 1 |
| Q3 FY2028 | $1.0B | $1.0B | $1.0B | 1 |
| Q2 FY2028 | $0.9B | $0.9B | $1.0B | 1 |
| Q1 FY2028 | $1.0B | $1.0B | $1.0B | 1 |
| Q4 FY2027 | $0.9B | $0.9B | $0.9B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 5, 2026 | -580.0% | $13.04 | $11.75 | -9.89% |
| ▼ Q1 FY2026 | Feb 24, 2026 | -20.6% | $10.29 | $8.86 | -13.90% |
| ▼ Q4 FY2025 | Nov 4, 2025 | -8.3% | $9.09 | $10.67 | +17.38% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -93.3% | $9.11 | $10.11 | +10.98% |
| ▲ Q2 FY2025 | May 6, 2025 | +0.0% | $8.70 | $8.85 | +1.72% |
| ▲ Q1 FY2025 | Feb 25, 2025 | +56.0% | $8.55 | $10.64 | +24.44% |
| ▼ Q4 FY2024 | Nov 5, 2024 | -11.8% | $10.15 | $9.18 | -9.56% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +10.5% | $10.97 | $8.66 | -21.06% |
Q2 FY2026-9.89%
Report Date
May 5, 2026
EPS Beat/Miss
-580.0%
Price Before
$13.04
Price After
$11.75
Q1 FY2026-13.90%
Report Date
Feb 24, 2026
EPS Beat/Miss
-20.6%
Price Before
$10.29
Price After
$8.86
Q4 FY2025+17.38%
Report Date
Nov 4, 2025
EPS Beat/Miss
-8.3%
Price Before
$9.09
Price After
$10.67
Q3 FY2025+10.98%
Report Date
Aug 5, 2025
EPS Beat/Miss
-93.3%
Price Before
$9.11
Price After
$10.11
Q2 FY2025+1.72%
Report Date
May 6, 2025
EPS Beat/Miss
+0.0%
Price Before
$8.70
Price After
$8.85
Q1 FY2025+24.44%
Report Date
Feb 25, 2025
EPS Beat/Miss
+56.0%
Price Before
$8.55
Price After
$10.64
Q4 FY2024-9.56%
Report Date
Nov 5, 2024
EPS Beat/Miss
-11.8%
Price Before
$10.15
Price After
$9.18
Q3 FY2024-21.06%
Report Date
Aug 6, 2024
EPS Beat/Miss
+10.5%
Price Before
$10.97
Price After
$8.66
Avg Beat Reaction+1.70%
Avg Miss Reaction-1.00%
Beat Rate3 / 8 quarters
Largest Move+24.44% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AHCO ends December
AdaptHealth Corp. (AHCO) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $-0.06 — missing the analyst consensus of $0.01 by -580.0%. The next AHCO earnings date is expected around September 1, 2026.
Each quarter, investors track AHCO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AHCO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AHCO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AHCO earnings · 5 questionsAdaptHealth Corp.'s next earnings report is expected around September 1, 2026. AHCO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AHCO historically reports after market close (AMC).
AHCO earnings datewhen is AHCO earningsAHCO next earnings datewhen does AHCO report earningsAHCO earnings calendar
▸ Source: FMP · AdaptHealth Corp. SEC filings · US GAAP · AdaptHealth Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026